Spineway : Signature of an exclusive agreement with the Japanese distributor MURANAKA Medical Instruments
23 Avril 2020 - 8:44AM
Spineway : Signature of an exclusive agreement with the Japanese
distributor MURANAKA Medical Instruments
Signature of an exclusive agreement with
the Japanese distributor MURANAKA Medical Instruments
Spineway, specialist in designing
innovative surgical implants and instruments for treating severe
disorders of the spinal column, announces the signature of an
exclusive agreement for the distribution of its products in Japan
with MURANAKA Medical Instruments.
This agreement follows on the heels of the
approval last October by the Japanese health authorities of
Spineway’s Mont-Blanc MIS minimally invasive surgical
line. Thanks to established know-how on the Asian
continent, Spineway will be able to rely on the sales
network and expertise of one of the biggest importers/distributers
of medical equipment in Japan to distribute its products on this
territory.
Based in Osaka, MURANAKA boasts annual
revenue of over 300 million euros and is established in Japan’s
largest cities. It has a neurosurgery division and distributes a
wide range of equipment and consumables (implants) to the main
Japanese hospitals.
Stéphane Le Roux, Chairman and CEO of
Spineway, said: “We are honored by and pleased with this
partnership with MURANAKA, which is the best partner possible for
the promotion of our Mont-Blanc MIS line in Japan. As soon as is
feasible, we will assist MURANAKA’s teams and provide guidance as
to the specifics and advantages of the Spineway systems in order to
develop sales of our premium implants in Japan.”
Thanks to this agreement, Spineway will
be able to distribute its implants on one of the world’s largest
spinal-surgery markets and spur its sales with higher added
value.
Upcoming: 26 May 2020 – General Meeting
SPINEWAY IS ELIGIBLE FOR THE PEA-PME
(EQUITY SAVINGS PLANS FOR SMES)
Find out all about Spineway at
www.spineway.com
This press release has been prepared in both
English and French. In case of discrepancies, the French version
shall prevail.
Spineway
designs, manufactures and markets innovative implants and surgical
instruments for treating severe disorders of the spinal
column.Spineway has an international network of
over 50 independent distributors and 90% of its revenue comes from
exports.Spineway, which is eligible for investment
through FCPIs (French unit trusts specializing in innovation), has
received the OSEO Excellence award since 2011 and has won the
Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation
award (2013) – INPI Talent award (2015). ISIN:
FR0011398874 - ALSPW
Contacts:
SPINEWAY Shareholder-services
lineAvailable Tuesday through
Thursday(10 a.m. – 12 p.m.)+33
(0)811 045 555 |
Eligible PEA / PMEALSPWEuronext Growth |
Aelium - Fiannce & communication
Investor relationsSolène
Kennisspineway@aelium.fr |
- CP_SPW_Japon_VD 202004 GB
Spineway (EU:ALSPW)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Spineway (EU:ALSPW)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024